Praful Bohra Explains Impact of Rupee Fall on Divis Lab, Dr Reddy's, Lupin

Praful Bohra of Religare Capital Markets says rupee depreciation will benefits pharma companies because they are net exporters and a lot of them do not have foreign debt. Stock Talk: Divis Lab is the most important beneficiary of rupee depreciation because there are no hedges. 75 per cent of their revenue comes from the US. Lupin has a large exposure to Japan. Almost 12 per cent of the company's revenues are in yen terms. It would...